Clinical Trials Search at Vanderbilt-Ingram Cancer Center

An Open-label, Phase 1 Dose Escalation and Phase 2 Dose Expansion Study to Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of SMP-3124LP in Adults with Advanced Solid Tumors

Disease Sites:

Not Available

Staging:

Phase I/II

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Eng, Cathy

Scope:

International

Participating Institutions:

Not Available

Open Date:

05-20-2025

Trial Type:

Treatment

Protocol ID:

VICC-DTPHI23348

National Clinical Trial ID:

NCT06526819

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available